SEC Form 4 · accession 0001203311-16-000123
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd E Simpson
Officer — Chief Financial Officer
Period of report
Aug 22, 2016
Accepted (ET)
Aug 22, 2016 · 9:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 22, 2016 | S | 3,991 | $46.5907 | D | 191,445 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- F2Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Includes 761 shares acquired under the Amended & Restated 2000 Employee Stock Purchase Plan on July 29, 2016.